In CLL, spectral flow cytometry analysis of PB from 10 ibrutinib‐responsive and eight relapsing patients showed an increase of proliferating CD8 T cells as well as in CD4 TFH cells in relapsed patients [28]. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.